Classification Information
Biological preparations for the treatment of COVID-19, namely, high concentrations of antibodies that target the spike and other protein formations of coronavirus; Biological preparations for prevention of COVID-19, namely, antibodies that target the ACE2 receptor in the upper respiratory and digestive tract; Biological preparations for the treatment of COVID-19, namely, antibodies that neutralize coronavirus in the upper respiratory tract, throat, pharynx, digestive tract and on the skin; biological preparations for the treatment of Covid-19 disease
Pharmaceuticals